The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,339K data for 617K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
The discovery of novel and selective fatty acid binding protein 4 inhibitors by virtual screening and biological evaluation.EBI
Chinese Academy Of Sciences
Novel fatty acid binding protein 4 (FABP4) inhibitors: virtual screening, synthesis and crystal structure determination.EBI
Chinese Academy Of Sciences
Interaction kinetics of liposome-incorporated unsaturated fatty acids with fatty acid-binding protein 3 by surface plasmon resonance.EBI
Osaka University
Structure-guided design, synthesis and in vitro evaluation of a series of pyrazole-based fatty acid binding protein (FABP) 3 ligands.EBI
Okayama University 1-1-1
New aromatic substituted pyrazoles as selective inhibitors of human adipocyte fatty acid-binding protein.EBI
Chinese Academy Of Sciences
Discovery of highly selective inhibitors of human fatty acid binding protein 4 (FABP4) by virtual screening.EBI
Chinese Academy Of Sciences
Identification and characterization of a small molecule inhibitor of Fatty Acid binding proteins.EBI
University Of Minnesota
N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors.EBI
Biovitrum
Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP).EBI
Bristol-Myers Squibb Pharmaceutical Research Institute
Substituted benzylamino-6-(trifluoromethyl)pyrimidin-4(1H)-ones: a novel class of selective human A-FABP inhibitors.EBI
Biovitrum
Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target.EBI
Biovitrum